USPTO guide
Restriction requirements and election of species
By Dharmik Patel, Co-founder, PatentAssist.ai
Updated
A restriction requirement is often the first thing an applicant hears from the USPTO, and it shapes the whole portfolio: which claims get examined now, which wait for a divisional, and which are lost if nobody acts. This guide explains the legal test the examiner has to meet, how to decide between electing with and without traverse, how rejoinder works, when to file the divisional, and how the answer differs in a national stage application, where unity of invention applies instead.
Quick answer
- Deadline: 2 months when there is no action on the merits, extendable to 6 months with fees (MPEP 710.02(b), 37 CFR 1.136(a)).
- You must elect: every reply has to elect one group or species, even if you disagree (37 CFR 1.143).
- Traverse with reasons: a general objection counts as no traverse and forfeits the 1.144 petition (MPEP 818.01(a), 818.01(c)).
- Plan for rejoinder: process claims that require every limitation of the elected product can come back in once the product is allowable (MPEP 821.04(b)).
- National stage is different: 371 applications are judged on unity of invention under 37 CFR 1.475, not on independence, distinctness and burden.
The legal basis: 35 U.S.C. 121
35 U.S.C. 121 lets the Director require an application to be restricted to one invention "if two or more independent and distinct inventions are claimed in one application." The same section gives the non-elected invention two protections: a divisional that meets section 120 keeps the parent's filing date, and a patent from the restricted application cannot be used as a reference against a divisional filed before that patent issues. The last sentence matters in litigation: a patent cannot be invalidated because the USPTO should have restricted it and did not.
The rules split the practice in two. 37 CFR 1.142 covers restriction between inventions; it is "normally made before any action on the merits" but may be made at any time before final action. 37 CFR 1.146 covers election of species, where a generic claim covers several patentably distinct species and the examiner asks you to pick one to search if the generic claim turns out not to be allowable.
What the examiner has to show
MPEP 803 sets two criteria, and a proper requirement needs both: (A) the inventions are independent or distinct as claimed, and (B) there would be a serious search and/or examination burden if restriction were not required. If everything can be searched and examined without serious burden, the examiner "must examine them on the merits, even though they include claims to independent or distinct inventions." An express admission that the inventions are obvious over each other also defeats restriction.
For burden, MPEP 808.02 accepts three showings for search: separate classification, a separate status in the art when classified together, or a different field of search, such as different classes or different search queries. Examination burden can instead rest on non-prior-art issues, for example a section 101 or 112(a) question that affects one group and not the other. Where classification and field of search are the same, the MPEP says "no reasons exist for dividing."
How distinctness is argued for each pairing
| Claimed together | When the examiner can call them distinct |
|---|---|
| Combination and subcombination MPEP 806.05(c) | Distinct if the combination as claimed does not require the particulars of the subcombination for patentability, and the subcombination has utility by itself or in other combinations. |
| Subcombinations usable together MPEP 806.05(d) | Distinct if they do not overlap in scope, are not obvious variants, and at least one has a separate use. |
| Process and apparatus for its practice MPEP 806.05(e) | Distinct if the process can be practiced by another materially different apparatus or by hand, or the apparatus can be used for a materially different process. |
| Process of making and product made MPEP 806.05(f) | Distinct if the process as claimed is not an obvious process of making the product and can make another materially different product, or the product can be made by another materially different process. |
| Product and process of using MPEP 806.05(h) | Distinct if the process of using can be practiced with another materially different product, or the product can be used in a materially different process. |
| Genus and species, or mutually exclusive species MPEP 806.04 | An election of species, not a restriction between inventions: you pick one species for search, and the generic claim is examined with it. |
The examiner must give reasons or examples, such as a materially different apparatus that could carry out the process, but usually does not need to cite documents. That is where most good traversals start: an example that is not materially different, or a "different field of search" that would in practice be the same search.
Your reply: the deadline and the election
A restriction or election requirement with no action on the merits sets a 2-month shortened statutory period (MPEP 710.02(b)). Extensions under 37 CFR 1.136(a) cost $235, $690, $1,590 and $2,495 for one to four months at the standard rate, with small entities paying 40% and micro entities 20% of those amounts (USPTO fee schedule). The reply can never run past 6 months from the action. Because the period starts at 2 months, a fourth-month extension is usable here, which it is not after a normal 3-month action.
Simple requirements often arrive by phone first. Under MPEP 812.01, the examiner may call the attorney or agent of record, explain the groups and ask for an oral election, generally with a second call within about 3 working days. You can decline and ask for a written requirement. If you do elect by phone, you must affirm it in the reply to the next action, so decide on traverse before the call back, not during it.
Three rules govern every written reply:
- You must elect. A complete reply includes an election even when you traverse, and the examiner will not elect for you (37 CFR 1.143, MPEP 818.01(b)).
- List the claims that read on the election. Identify every claim, including generic and linking claims, that covers the elected group or species. An election of species also needs the claims that read on that species.
- Answer anything else in the action. If a rejection or objection came with the requirement, you must address it too (MPEP 818.01).
Election becomes fixed once the elected claims get an action on the merits. Claims you add later to a different invention are withdrawn, because the invention first examined is treated as elected by original presentation (MPEP 818.02(a)). This applies in any RCE too, so a request for continued examination is not a way to switch inventions.
Traverse or not: the decision table
| Option | Use it when | What follows |
|---|---|---|
| Elect without traverse | The groups really are different inventions and you are happy to pursue them separately. | Fastest. You give up any later petition under 37 CFR 1.144. Non-elected claims are withdrawn and can go into a divisional. |
| Elect with traverse | The examiner has not shown a serious search or examination burden, or the groups are obvious variants of each other. | Requires specific reasons (MPEP 818.01(a)). The requirement is reconsidered, and if repeated and made final you keep the right to petition, no later than the notice of appeal. |
| Elect and argue a linking claim is allowable | A generic or linking claim ties the groups together and you expect it to be allowed. | This is not a traverse (MPEP 818.01(d)). If the linking claim is allowed the restriction must be withdrawn; if not, you have conceded the restriction is proper. |
| Elect, then shape claims for rejoinder | You elect the product and still want process claims in the same patent. | Process claims that depend from or require all the limitations of the elected product can be rejoined once the product is allowable (MPEP 821.04(b)). |
| Elect and file a divisional early | The non-elected group matters commercially and cannot be rejoined. | Starts examination of the second group sooner, with the 35 U.S.C. 121 shield against nonstatutory double patenting, at the cost of a second set of filing fees. |
A traverse is a request for reconsideration that must "distinctly and specifically" point out the errors (MPEP 818.01(a)). "Applicant elects Group I with traverse" and nothing more is treated as an election without traverse. Good grounds are concrete: the groups share a classification and the examiner has given no different search strategy; the materially different product the examiner suggests is not actually made by the claimed process; or the species are obvious variants, in which case say so expressly, accepting that the admission can be used against you on obviousness.
A traverse buys a reconsidered requirement, not a fast reversal. If the examiner repeats the requirement and makes it final, the next action also examines the elected claims (37 CFR 1.143). You can then petition the Director under 37 CFR 1.144. The petition can wait until final action on or allowance of the elected claims, but must be filed no later than the notice of appeal. Restriction is petitionable, not appealable: the Patent Trial and Appeal Board will not review it in an ex parte appeal.
Rejoinder: getting withdrawn claims back
When the elected claims are ready for allowance, the examiner reconsiders the restriction and looks at rejoinder (MPEP 821.04). A withdrawn claim is eligible only if it depends from or otherwise requires all the limitations of an allowable claim. In a product and process split where you elected the product, every claim to the non-elected process must meet that test before the process group is rejoined (MPEP 821.04(b)). The MPEP warns that failing to amend non-elected claims to require the elected invention "may result in a loss of the right to rejoinder."
Rejoined claims are fully examined under sections 101, 102, 103 and 112, and the restriction between the rejoined groups is withdrawn. That has a cost: once the restriction is withdrawn, the 121 shield no longer protects a divisional covering the same ground, and a double patenting rejection can follow (MPEP 821.04, citing In re Ziegler). If you would rather keep the process for a divisional, cancel the process claims before rejoinder; the examiner then leaves the restriction in place to preserve your rights under section 121.
Worked example
An application claims a coated stent (claims 1 to 10), a method of making it (claims 11 to 15) and a method of treating a patient by implanting it (claims 16 to 20). The examiner restricts into three groups under MPEP 806.05(f) and 806.05(h), saying the stent could be made by a materially different spraying process and used in a different procedure. You elect Group I, the stent, without traverse, because the burden showing is solid. In the same reply you amend claims 11 and 16 to recite "the stent of claim 1." When claim 1 is allowed, the method claims qualify for rejoinder and the patent can issue with all three groups, with no divisional fees. Had you left claim 11 reciting a generic "drug-eluting implant," it would not require every limitation of claim 1 and would stay withdrawn.
Divisional strategy
A divisional must be filed while the parent is still pending, which means before it issues or is abandoned, to claim its filing date under section 120. It is a new application with its own filing, search and examination fees: $350, $770 and $880 at the standard rate, $2,000 in total before any excess claim or size fees (USPTO patent fees). If it is filed more than six years after the earliest date whose benefit it claims, the continuing application fee under 37 CFR 1.17(w) applies: $2,700 standard after six years and $4,000 after nine. In long families, that alone is a reason not to leave divisionals to the last minute.
The double patenting shield in section 121 is narrow. MPEP 804.01 lists where it does not apply. Three matter most in practice:
- Applications you file voluntarily, without a restriction requirement. To get the benefit, the claims must have been entered, restricted and removed from the earlier application.
- Continuations and continuations-in-part. The Federal Circuit held in Pfizer v. Teva (2008) that the protection "is limited to divisional applications," and later cases refused to let patentees relabel a CIP after the fact.
- Divisional claims that drift across the line of the restriction and claim what was examined in the parent.
Timing is a business decision. Filing the divisional soon after the election gets the second group into the examination queue early, which helps where a competitor's product reads on it. Waiting lets the parent's prosecution history settle the claim language and the prior art first. Either way, docket the parent's allowance: once the issue fee is paid, the window to file closes on the issue date. If speed matters, a divisional can carry its own Track One request from filing; a request in the parent does not carry over.
Unity of invention in 371 national stage cases
If your US case is the national stage of a PCT application, the examiner applies unity of invention under 37 CFR 1.475 and 1.499, not the independent-and-distinct test. MPEP 1893.03(d) reminds examiners of this and requires them to list the groups and explain the unique special technical feature of each. The examiner may raise lack of unity even if the International Searching Authority did not.
| Restriction (111(a)) | Unity of invention (371) | |
|---|---|---|
| Which applications | Applications filed under 35 U.S.C. 111(a), including bypass continuations of a PCT application | National stage applications under 35 U.S.C. 371 |
| Legal test | Inventions are independent or distinct, and examining them together would be a serious burden (MPEP 803) | Inventions share a special technical feature that makes a contribution over the prior art (37 CFR 1.475(a)) |
| Role of search burden | Required. Separate classification, separate status in the art or a different field of search (MPEP 808.02) | Not part of the test. The examiner must identify the special technical feature of each group (MPEP 1893.03(d)) |
| Product, process of making and use | Often restricted three ways where the process of making is distinct from the product (37 CFR 1.141(b)) | Allowed together if the process is specially adapted to make the product and the use is a use of that product (37 CFR 1.475(b)) |
| Review | Traverse, then petition under 37 CFR 1.144 | The same: 37 CFR 1.499 points to 1.143 and 1.144 |
Two practical consequences follow. First, a lack of unity objection is answered on the prior art: if the feature the groups share is new and inventive, it is a special technical feature and unity exists. "The examiner has not shown a search burden" is not an argument in a 371 case. Second, the choice of route changes the test. A bypass continuation filed under 111(a) that claims the PCT application is examined under restriction practice even though its claims are the same (MPEP 1893.03(d)). Product, process and use claims that a national stage keeps together under 1.475(b) may be split three ways in the bypass case.
European practice uses the same unity standard as the PCT. If the EPO, as International Searching Authority, charged additional search fees for lack of unity in your PCT application, read its reasoning before the US national stage; it often predicts the US groups. See our guide to the European patent application for how the EPO handles unity and divisionals on its side.
Drafting to avoid a costly restriction
Most restrictions are predictable from the claim set. Writing method claims that recite the claimed product, rather than a looser version of it, keeps them eligible for rejoinder. A strong generic claim with species in dependent form follows 37 CFR 1.141(a), which allows a reasonable number of species in one application where there is an allowable generic claim. And keeping the core feature in every independent claim gives you a special technical feature to point to in a national stage. The claim structure principles are covered in how to write patent claims.
A restriction is not the end of examination, only the start. The first action on the merits usually follows within months; see how to respond to a USPTO office action for the rejections that come next.
Build the claim set before the examiner splits it
PatentAssist.ai drafts claims and specifications in USPTO format, and you can direct the claim structure: a generic independent claim, species in dependent claims, and method claims that recite the claimed product so they stay eligible for rejoinder. Its prior-art search covers USPTO, EPO and Indian records, which helps you judge whether a shared feature is really new before you argue unity. It does not prepare replies to US office actions; that work stays with you or your practitioner.
More USPTO guides
- How to file a provisional patent application (US)
What a US provisional must contain, the USPTO fees, the 12-month deadline under 35 U.S.C. 119(e), and when to skip it.
- USPTO patent fees (2026)
Every USPTO patent fee for large, small and micro entities, from filing to maintenance, with a fee calculator.
- Patent drawing requirements: USPTO, EPO and India
37 CFR 1.84, the EPO rules that replaced Rule 46 EPC, and Indian rule 15, compared side by side.
- How to write patent claims: USPTO, EPO and India
Claim structure and worked examples, then the claim rules and fees at the USPTO, the EPO and the Indian Patent Office, side by side.
- How to respond to a USPTO office action
Reply deadlines and extension fees, 101, 102, 103 and 112 rejections, interviews, and options after a final rejection.
- Types of patent searches, and which one you need
Patentability, freedom-to-operate, invalidity and landscape searches compared by purpose, timing, scope and deliverable.
- Patentability search: how to check novelty before you file
What counts as prior art under 35 U.S.C. 102 and Art. 54 EPC, the grace period gap, search steps and how to read results.
- Freedom-to-operate search in the US and Europe
In-force claims only, legal status checks at the USPTO, EPO and UPC, FTO opinions after Halo, and design-arounds.
- Invalidity search: prior art to challenge a patent
IPR, PGR, EPO opposition and UPC revocation deadlines, prior art dates, standards documents and claim charts.
- Patent landscape analysis, step by step
Building a CPC and keyword dataset, cleaning families and names, the metrics that matter and the 18-month publication lag.
- How to use USPTO Patent Public Search
Basic and Advanced Search, the three databases, field codes, ADJ, NEAR, WITH and SAME, truncation and a worked search.
- Google Patents search guide
Search operators and fields, Boolean and proximity syntax, non-patent literature, and where Google Patents falls short of the official databases.
- The Cooperative Patent Classification (CPC), explained
How CPC symbols are built, CPC against IPC, the Y section, how to find the right class and how to search it in each database.
- Patent search Boolean operators and search strings
Boolean, proximity and truncation syntax compared across Patent Public Search, Espacenet, Google Patents and The Lens, with semantic search for contrast.
- How to respond to a 35 U.S.C. 101 rejection
The Alice/Mayo steps in MPEP 2106, Ex parte Desjardins and the 2024-2026 USPTO guidance, Berkheimer evidence and Rule 132 eligibility declarations.
- How to respond to a 35 U.S.C. 102 rejection
Anticipation under MPEP 2131, AIA 102(a)(1) and (a)(2), the 102(b) exceptions, inherency and Rule 130 declarations.
- How to respond to a 35 U.S.C. 103 rejection
Graham and the KSR rationales in MPEP 2143, teaching away, motivation to combine, secondary considerations with nexus, and Rule 132 evidence.
- How to respond to a 35 U.S.C. 112 rejection
Written description and enablement after Amgen, 112(b) indefiniteness, 112(f) means-plus-function after Williamson, and 112(d) dependent claims.
- The PCT application: timeline, fees and national phase
The international phase month by month, receiving Office and ISA fees in CHF, USD and EUR, national phase deadlines by office, and a deadline calculator.
- Entering the US national stage under 35 U.S.C. 371
The 30-month deadline and revival, the 371 requirements, national stage fees by entity size, and 371 versus a bypass continuation.
- The US foreign filing license (35 U.S.C. 184)
When a US-made invention needs a license to be filed abroad, the six-month rule, expedited and retroactive licenses, and the Indian and European equivalents.
- Filing a US patent from Europe or India
The 2026 US practitioner rule for foreign applicants, Paris priority and certified copies, small entity status, PCT or direct, fees and translations.
- What is a utility patent?
What a US utility patent covers under 35 U.S.C. 101, the parts of the application in 37 CFR 1.77 order, the 20-year term and USPTO costs.
- Design patents in the United States
What a design patent protects, drawings and the single claim, the 15-year term, Hague filings, LKQ v. GM, and design vs utility patents.
- How to file a nonprovisional patent application
Required parts and fees, claiming a provisional within 12 months, DOCX filing in Patent Center, and what happens after you file.
- Provisional vs nonprovisional patent application
The two US filings side by side, the cost of each route, the effect on term and publication, and a guide to which to file.
- Continuation, CIP and divisional applications
Copendency, patent term, double patenting and terminal disclaimers, the 2025 continuing application fee, and continuation strategy.
- How much does a patent cost?
USPTO fees by entity size from filing to the last maintenance fee, what drives professional fees, EPO fees, and an estimator.
- How to patent an idea in the US
Nine steps from patentability and search to provisional filing, Patent Center, examination and maintenance, with the USPTO's free help programs.
- Small entity vs micro entity status
Who qualifies under 37 CFR 1.27 and 1.29, the 2026 income limit, SB/15A and SB/15B, license traps, fixing errors, and an eligibility checker.
- How long does a patent last?
US utility and design terms, patent term adjustment and extension, terminal disclaimers, maintenance fee deadlines, Europe and India, with an expiry estimator.
- Can AI write a patent application?
What AI drafting does well and badly, the USPTO and EPO positions on AI tools, AI inventorship after 2025, and confidentiality.
- Options after a final rejection
Amendment after final, advisory actions, the end of AFCP 2.0, RCE, pre-appeal and appeal, with fees, timing and USPTO outcome data.
- Request for continued examination (RCE)
What 37 CFR 1.114 requires, first and later RCE fees, patent term effects, and when an RCE beats an appeal.
- Information disclosure statements (IDS)
The duty of disclosure, IDS timing windows and fees, the 2025 size fee, EPO search reports, Therasense and QPIDS.
- PTAB ex parte appeals
Notice of appeal to decision step by step, with fees, deadlines and the PTAB's FY 2026 pendency and outcome statistics.
- Track One prioritized examination
Track One requirements, fees by entity size, the 20,000 annual cap and USPTO timing data, plus PPH and age or health petitions.
- 35 U.S.C., annotated: US patent law section by section
The current text of 34 key sections of Title 35 with plain-English summaries, key cases, 37 CFR rules and MPEP references.
Restriction requirements: frequently asked questions
What is a restriction requirement?
It is an office action telling you that your claims cover two or more independent or distinct inventions and that you must pick one to be examined in this application (35 U.S.C. 121, 37 CFR 1.142). It usually comes before any action on the merits. The claims you do not elect are withdrawn, and you can pursue them in a divisional application.
How long do I have to respond to a restriction requirement?
A restriction or election of species requirement with no action on the merits sets a 2-month shortened period (MPEP 710.02(b)). You can extend it month by month under 37 CFR 1.136(a), up to 6 months from the action. At the standard rate a first-month extension costs $235, a second $690 and a third $1,590.
Should I elect with or without traverse?
Traverse only when you have a specific reason the requirement is wrong, such as no real search burden or groups that are obvious variants of each other. A traverse must point out the errors distinctly; a bare statement that you traverse is treated as an election without traverse (MPEP 818.01(a)). Only a traversed requirement can later be petitioned under 37 CFR 1.144.
What is rejoinder?
Rejoinder is the examiner withdrawing a restriction between an allowable elected invention and a non-elected one, then examining the non-elected claims (MPEP 821.04). A withdrawn claim qualifies only if it depends from or otherwise requires all the limitations of an allowable claim, so keep process claims written to require the elected product.
Can I appeal a restriction requirement to the PTAB?
No. A restriction requirement is reviewed by petition to the Director under 37 CFR 1.144, not by appeal. You must have traversed it, it must have been made final, and the petition must be filed no later than the notice of appeal.
Does a divisional application protect me from double patenting?
Yes, within limits. The third sentence of 35 U.S.C. 121 stops a patent from the restricted application being used as a reference against a divisional filed before that patent issues. The Federal Circuit has held that the shield covers divisionals only, not continuations (Pfizer v. Teva, cited in MPEP 804.01), and the divisional's claims must stay within the restricted-out group.
Sources: 35 U.S.C. 121; 37 CFR 1.141, 1.142, 1.143, 1.144, 1.146, 1.475 and 1.499 (eCFR, current to October 22, 2026); MPEP (Ninth Edition, Revision 01.2024) sections 710.02(b), 803, 804.01, 806, 808.02, 812.01, 818, 821.04 and 1893.03(d); USPTO fee schedule (effective January 19, 2025, revised August 14, 2026). This guide is general information, not legal advice. Have a registered patent attorney or agent review your reply.